Perugia, Italy

Romani Luigina

This inventor holds 1 USPTO granted patent. Top assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Romani Luigina. Retrieved from https://idiyas.com/inventor/romani-luigina

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Romani Luigina: Innovator in Fungal Infection Treatment

Introduction

Romani Luigina is a notable inventor based in Perugia, Italy. He has made significant contributions to the field of medicine, particularly in the treatment of fungal infections. His innovative approach combines existing antifungal agents with a novel compound, showcasing his commitment to advancing healthcare solutions.

Latest Patents

Luigina holds a patent for a medicament aimed at treating fungal infections, specifically aspergillosis. The patent describes a combination of pentraxin PTX3 with antifungal agents. This combination leverages the synergistic effect of both drugs, allowing for the administration of suboptimal doses of antifungal agents, which can enhance treatment efficacy and reduce potential side effects.

Career Highlights

Luigina is associated with Sigma-Tau Industrie Farmaceutiche Riunite S.p.A., a company known for its focus on pharmaceutical innovations. His work has been instrumental in developing new therapeutic strategies that address challenging medical conditions.

Collaborations

Luigina collaborates with esteemed colleagues such as Paolo Carminati and Giovanni Salvatori. Their combined expertise contributes to the advancement of research and development in the pharmaceutical sector.

Conclusion

Romani Luigina's contributions to the treatment of fungal infections highlight his innovative spirit and dedication to improving patient outcomes. His work exemplifies the importance of collaboration and creativity in the field of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…